LawrenceD.KaplanMD
Oncology • San Francisco, CAHematologic Oncology
Clinical Professor of Medicine, UCSF
Dr. Kaplan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1983 - 1985
Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
David Geffen School of Medicine at UCLAClass of 1980
Certifications & Licensure
CA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jan 01
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jan 01
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 61 citationsCryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial.Jordan W. Tappero, Timothy G. Berger, Lawrence D. Kaplan, Paul A. Volberding, James O. Kahn
Journal of Acquired Immune Deficiency Syndromes. 1991-01-01 - 123 citationsTreatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.Stefan K. Barta, Xiaonan Xue, Dan Wang, Roni Tamari, Jeannette Y. Lee
Blood. 2013-11-07 - 65 citationsAMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphomaAriela Noy, Jeannette Y. Lee, Ethel Cesarman, Richard F. Ambinder, Robert A. Baiocchi
Blood. 2015-07-09
Abstracts/Posters
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Lawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...Lawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaLawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
OncLive® Presents State of the Science Summit™: Hematologic MalignanciesDecember 5th, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
